IDEXX LABORATORIES INC /DE Tax Withholding Paid on Stock Awards
IDEXX LABORATORIES INC /DE (IDXX) reported Tax Withholding Paid on Stock Awards of $10.85 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2026-08-04
- IDEXX LABORATORIES INC /DE payment, tax withholding, share-based payment arrangement for the quarter ending 2026-06-30 was $298.00K, a 69.28% decline year-over-year.
- IDEXX LABORATORIES INC /DE payment, tax withholding, share-based payment arrangement for the quarter ending 2026-03-31 was $10.55M, a 72.35% increase year-over-year.
- IDEXX LABORATORIES INC /DE payment, tax withholding, share-based payment arrangement for the quarter ending 2025-12-31 was $60.00K, a 33.33% increase year-over-year.
- IDEXX LABORATORIES INC /DE payment, tax withholding, share-based payment arrangement for the quarter ending 2025-09-30 was $85.00K, a 61.01% decline year-over-year.
- IDEXX LABORATORIES INC /DE payment, tax withholding, share-based payment arrangement for fiscal 2025 was $7.24M, a 31.26% decline from fiscal 2024.
- IDEXX LABORATORIES INC /DE payment, tax withholding, share-based payment arrangement for fiscal 2024 was $10.53M, a 5.57% increase from fiscal 2023.
- IDEXX LABORATORIES INC /DE payment, tax withholding, share-based payment arrangement for fiscal 2023 was $9.97M, a 5.95% decline from fiscal 2022.
- IDEXX LABORATORIES INC /DE payment, tax withholding, share-based payment arrangement for fiscal 2022 was $10.61M, a 31.85% decline from fiscal 2021.
| Period end | Payment, Tax Withholding, Share-based Payment Arrangement 3 month | Payment, Tax Withholding, Share-based Payment Arrangement 6 month | Payment, Tax Withholding, Share-based Payment Arrangement 9 month | Payment, Tax Withholding, Share-based Payment Arrangement 12 month |
|---|---|---|---|---|
| 2026-06-30 | $298.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $10.85M 10-Q · filed 2026-08-04 | $10.91M derived: sum of 3 quarters · filed 2026-08-04 | $11.00M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $10.55M 10-Q · filed 2026-05-05 | $10.62M derived: sum of 2 quarters · filed 2026-05-05 | $10.70M derived: sum of 3 quarters · filed 2026-05-05 | $11.67M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $60.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $145.00K derived: sum of 2 quarters · filed 2026-02-20 | $1.11M derived: sum of 3 quarters · filed 2026-08-04 | $7.24M 10-K · filed 2026-02-20 |
| 2025-09-30 | $85.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $1.05M derived: sum of 2 quarters · filed 2026-08-04 | $7.18M 10-Q · filed 2025-11-03 | $7.22M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $970.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $7.09M 10-Q · filed 2026-08-04 | $7.14M derived: sum of 3 quarters · filed 2026-08-04 | $7.36M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $6.12M 10-Q · filed 2026-05-05 | $6.17M derived: sum of 2 quarters · filed 2026-05-05 | $6.39M derived: sum of 3 quarters · filed 2026-05-05 | $6.47M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $45.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $263.00K derived: sum of 2 quarters · filed 2026-02-20 | $342.00K derived: sum of 3 quarters · filed 2026-02-20 | $10.53M 10-K · filed 2026-02-20 |
| 2024-09-30 | $218.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $297.00K derived: sum of 2 quarters · filed 2025-11-03 | $10.49M 10-Q · filed 2025-11-03 | $10.55M derived: sum of 4 quarters · filed 2026-02-20 |
| 2024-06-30 | $79.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | $10.27M 10-Q · filed 2025-08-04 | $10.34M derived: sum of 3 quarters · filed 2026-02-20 | $10.57M derived: sum of 4 quarters · filed 2026-02-20 |
| 2024-03-31 | $10.19M 10-Q · filed 2025-05-01 | $10.26M derived: sum of 2 quarters · filed 2026-02-20 | $10.49M derived: sum of 3 quarters · filed 2026-02-20 | $10.57M derived: sum of 4 quarters · filed 2026-02-20 |
| 2023-12-31 | $68.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $299.00K derived: sum of 2 quarters · filed 2026-02-20 | $378.00K derived: sum of 3 quarters · filed 2026-02-20 | $9.97M 10-K · filed 2026-02-20 |
| 2023-09-30 | $231.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $310.00K derived: sum of 2 quarters · filed 2024-10-31 | $9.91M 10-Q · filed 2024-10-31 | $9.96M derived: sum of 4 quarters · filed 2025-02-21 |
| 2023-06-30 | $79.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $9.68M 10-Q · filed 2024-08-06 | $9.73M derived: sum of 3 quarters · filed 2025-02-21 | $9.89M derived: sum of 4 quarters · filed 2025-02-21 |
| 2023-03-31 | $9.60M 10-Q · filed 2024-05-01 | $9.65M derived: sum of 2 quarters · filed 2025-02-21 | $9.81M derived: sum of 3 quarters · filed 2025-02-21 | $9.87M derived: sum of 4 quarters · filed 2025-02-21 |
| 2022-12-31 | $54.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-21 | $216.00K derived: sum of 2 quarters · filed 2025-02-21 | $268.00K derived: sum of 3 quarters · filed 2025-02-21 | $10.61M 10-K · filed 2025-02-21 |
| 2022-09-30 | $162.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $214.00K derived: sum of 2 quarters · filed 2023-11-01 | $10.55M 10-Q · filed 2023-11-01 | $10.61M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | $52.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | $10.39M 10-Q · filed 2023-08-01 | $10.45M derived: sum of 3 quarters · filed 2024-02-22 | $11.00M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | $10.34M 10-Q · filed 2023-05-02 | $10.40M derived: sum of 2 quarters · filed 2024-02-22 | $10.95M derived: sum of 3 quarters · filed 2024-02-22 | $10.92M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $61.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $610.00K derived: sum of 2 quarters · filed 2024-02-22 | $579.00K derived: sum of 3 quarters · filed 2024-02-22 | $15.56M 10-K · filed 2024-02-22 |
| 2021-09-30 | $549.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | $518.00K derived: sum of 2 quarters · filed 2022-11-01 | $15.50M 10-Q · filed 2022-11-01 | $27.07M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-06-30 | -$31.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $14.95M 10-Q · filed 2022-08-02 | $26.53M derived: sum of 3 quarters · filed 2023-02-16 | $26.89M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-03-31 | $14.98M 10-Q · filed 2022-05-04 | $26.56M derived: sum of 2 quarters · filed 2023-02-16 | $26.92M derived: sum of 3 quarters · filed 2023-02-16 | $26.98M derived: sum of 4 quarters · filed 2023-02-16 |
| 2020-12-31 | $11.57M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $11.94M derived: sum of 2 quarters · filed 2023-02-16 | $12.00M derived: sum of 3 quarters · filed 2023-02-16 | $20.60M 10-K · filed 2023-02-16 |
| 2020-09-30 | $361.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $425.00K derived: sum of 2 quarters · filed 2021-11-02 | $9.03M 10-Q · filed 2021-11-02 | $9.23M derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-06-30 | $64.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | $8.67M 10-Q · filed 2021-07-30 | $8.87M derived: sum of 3 quarters · filed 2022-02-16 | $9.15M derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-03-31 | $8.60M 10-Q · filed 2021-05-04 | $8.81M derived: sum of 2 quarters · filed 2022-02-16 | $9.09M derived: sum of 3 quarters · filed 2022-02-16 | $9.25M derived: sum of 4 quarters · filed 2022-02-16 |
| 2019-12-31 | $204.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $481.00K derived: sum of 2 quarters · filed 2022-02-16 | $650.00K derived: sum of 3 quarters · filed 2022-02-16 | $8.05M 10-K · filed 2022-02-16 |
| 2019-09-30 | $277.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $446.00K derived: sum of 2 quarters · filed 2020-10-29 | $7.85M 10-Q · filed 2020-10-29 | $8.11M derived: sum of 4 quarters · filed 2021-02-12 |
| 2019-06-30 | $169.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | $7.57M 10-Q · filed 2020-07-31 | $7.84M derived: sum of 3 quarters · filed 2021-02-12 | $8.23M derived: sum of 4 quarters · filed 2021-02-12 |
| 2019-03-31 | $7.40M 10-Q · filed 2020-04-30 | $7.67M derived: sum of 2 quarters · filed 2021-02-12 | $8.06M derived: sum of 3 quarters · filed 2021-02-12 | $8.22M derived: sum of 4 quarters · filed 2021-02-12 |
| 2018-12-31 | $265.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12 | $655.00K derived: sum of 2 quarters · filed 2021-02-12 | $820.00K derived: sum of 3 quarters · filed 2021-02-12 | $9.38M 10-K · filed 2021-02-12 |
| 2018-09-30 | $390.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $555.00K derived: sum of 2 quarters · filed 2019-10-31 | $9.11M 10-Q · filed 2019-10-31 | $9.35M derived: sum of 4 quarters · filed 2020-02-14 |
| 2018-06-30 | $165.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $8.72M 10-Q · filed 2019-08-01 | $8.96M derived: sum of 3 quarters · filed 2020-02-14 | $9.33M derived: sum of 4 quarters · filed 2020-02-14 |
| 2018-03-31 | $8.55M 10-Q · filed 2019-05-01 | $8.80M derived: sum of 2 quarters · filed 2020-02-14 | $9.17M derived: sum of 3 quarters · filed 2020-02-14 | $9.32M derived: sum of 4 quarters · filed 2020-02-14 |
| 2017-12-31 | $244.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-14 | $614.00K derived: sum of 2 quarters · filed 2020-02-14 | $770.00K derived: sum of 3 quarters · filed 2020-02-14 | $8.07M 10-K · filed 2020-02-14 |
| 2017-09-30 | $370.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $526.00K derived: sum of 2 quarters · filed 2018-11-01 | $7.83M 10-Q · filed 2018-11-01 | $8.47M derived: sum of 4 quarters · filed 2019-02-15 |
| 2017-06-30 | $156.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | $7.46M 10-Q · filed 2018-08-01 | $8.10M derived: sum of 3 quarters · filed 2019-02-15 | $8.10M derived: sum of 4 quarters · filed 2019-02-15 |
| 2017-03-31 | $7.30M 10-Q · filed 2018-05-04 | $7.94M derived: sum of 2 quarters · filed 2019-02-15 | $7.94M derived: sum of 3 quarters · filed 2019-02-15 | $7.91M derived: sum of 4 quarters · filed 2019-02-15 |
| 2016-12-31 | $640.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-15 | $640.00K derived: sum of 2 quarters · filed 2019-02-15 | $608.00K derived: sum of 3 quarters · filed 2019-02-15 | $4.37M 10-K · filed 2019-02-15 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | -$32.00K derived: sum of 2 quarters · filed 2017-10-31 | $3.73M 10-Q · filed 2017-10-31 | |
| 2016-06-30 | -$32.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | $3.73M 10-Q · filed 2017-08-01 | ||
| 2016-03-31 | $3.76M 10-Q · filed 2017-04-28 | |||
| 2015-12-31 | $5.44M 10-K · filed 2018-02-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |